Examining the Deficit Narrative

This chapter addresses the deficit-laden narratives about Black boys by offering a dramatic alternative, that is, a paradigm shift to recognize and value the funds of knowledge of Black boys, and in doing so, redefine the constructs of success for Black boys. As a starting point, the author contends that researchers, teachers, school and district administrators, and policymakers must unequivocally reject and rebuke current deficit-based narratives about Black boys. These false narratives, which are harmful to Black boys, make it impossible for them ever to find success or be viewed as successful in K-12 education. A critical paradigm was selected as most appropriate. Using the African American Male Theory as well as an Anti-Deficit Framework, this chapter will highlight the funds of knowledge of Black boys to demonstrate counter-stories of their learning and successes, and in doing so, not only rewrite the deficit narratives of Black boys, but also broaden academia's perspective on how we define knowledge and whose knowledge counts.

Attitudinal Judgments of Dialect Traits and Colorism in African Americans

This study demonstrates how language and complexion influence professional and social perceptions of African Americans. This study contains an online verbal-guise survey where participants either saw a photo of a lighter skin-toned African-American male and female or an electronically darkened version. Audio was attached to each photo, which contains traits of African-American Vernacular English (AAVE) in the case of the male and Standard American English for the female. The results suggest African-American females are more likely to experience colorism in professional traits while African-American males are more likely to experience colorism in social traits. Additionally, the respondent’s race influences perceptions of AAVE.

Blinatumomab resistant clone presenting as mixed phenotype myeloid sarcoma causing cord compression

Introduction/Objective Blinatumomab is a monoclonal antibody directed against CD19/CD3 utilized for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) and for the treatment of B-cell precursor ALL in first or second complete remission with minimal residual disease (MRD) ≥0.1%. Although Blinatumomab treatment has shown better overall survival, progression-free survival, and complete remission when compared to chemotherapy, most patients have a relapse and ultimately succumb to the disease. Interestingly, there are a number of cases reporting relapse in extramedullary places. The mechanisms for relapse in these unusual extramedullary sites are not well-understood. We herein report a case of a 20-year-old African American male with primary refractory Philadelphia-negative (Ph-) precursor B cell ALL with MLL rearrangement, who received treatment with Blinatumomab after achieving morphological remission with a pediatric-inspired regimen but found to be MRD +. Methods/Case Report A 20 year old African American male was found to have B cell precursor ALL. It was found to be Ph-. While initally receiving vincristine, prednisone, and aspariginase, the ALL proved to be refractory to treatment. Blinatumomab was used as second line therapy after the first failed remission. The patient remained with morphological response; however, remained MRD+ after three cycles of Blinatumomab. During the fourth cycle, the patient presented with back pain and lower extremity weakness. A spine MRI revealed an extradural mass in the thoracic spine causing cord compression. A thoracic laminectomy with partial removal of the mass, followed by radiation, was performed with improvement of symptoms. Pathology results of the extradural mass revealed a myeloid sarcoma with MLL rearrangement. Results (if a Case Study enter NA) NA Conclusion This case report demonstrates how patients treated with blinatumomab can have relapse in unusual extramedullary places. The possibility of leukemia manifesting in extramedullary sites should always be kept in mind by clinicians treating patients with Blinatumomab. The mechanisms of resistance against Blinatumomab are not well- understood and need further elucidation.

Bullous reaction to cupping therapy

A 54-year-old African American male presented with pruritic, circular, purpuric lesions, following a cupping service 4 days prior. The patient had a history of eczematoid dermatitis, scalp folliculitis and xerosis cutis. Upon examination, 13 lesions were identified with a diameter of 6 cm each. These lesions contained both bullae and vesicles concentrated along the perimeter of the lesions. All lesions showed varying degrees of ecchymosis. The diagnosis of iatrogenic-induced bullae was made and topical zinc-oxide astringent ointment was prescribed for BID use. Follow up examination revealed significant healing with all bullae flattened. The patient reported no pain but had minor complaints of residual pruritic hyperpigmentation. He was prescribed Triamcinolone Acetonide 0.005% ointment BID for these areas with good recovery.

A-59 Psychosis and Coma in COVID-19: A Case Report

Objective The objective of this case is to spotlight the potential neurological andneuropsychiatric symptoms associated with COVID-19. Method A 55-year-old African American male with a history of schizophrenia, bipolar disorder, obesity, tobacco use, and hypertension voluntarily presented to the local hospital with auditoryhallucinations and delusions. During an inpatient stay, the patient developed symptomsconsistent with COVID-19 and subsequently tested positive for the virus. Thirty-nine days after the initial positive COVID-19 test result, he remained in a coma with retained brainstem responses. An EEG demonstrated encephalopathy and MRI showed multiple, well-circumscribed white matter lesions consistent with acute demyelination (Figure 1). After three days of high-dose steroids and over a month in a coma, the patient began following simple commands. Unfortunately, on hospital day 66, the patient developed sudden hypotension and worsening respiratory status. Results While psychotic episodes in relation to COVID-19 are not widely reported, psychotic episodes are shown in three COVID-19 cases. Other reports have found significant changes in consciousness in COVID-19 patients with delayed awakening from a comatose state. Pre-existing inflammatory responses in those with psychiatric disease may be accelerated by the immune response due to COVID-19. Conclusion Mental status changes in those with psychiatric illness who have COVID-19 are worth exploring. It is unclear whether a history of COVID-19 may accelerate a neuropsychiatric process or other central nervous system diseases. Future research may want to examine the possible interrelationship between pre-existing neurological vulnerabilities and COVID-19. The possibility of high-dose steroid treatment for COVID-19 neuroinflammatory complications should be considered.

Successful Treatment of Inguinal Lymphocele After Angiomyomatous Hamartoma Resection During Inguinal Hernia Repair

Introduction. Lymphocele is a relatively common complication following lymphadenectomy of the inguinal lymph nodes; however, it is less common after open inguinal hernia repair. Postoperative lymphocele is usually caused by unrecognized injury to lymphatic vessels during surgical dissection and commonly requires reoperation to ligate the leaking lymphatics. Angiomyomatous hamaromas are rare lymphatic formations of unknown cause that can be treated with aspiration, sclerotherapy, and drain placement, but surgical intervention is often required. This finding is associated with replacement of parenchymal lymph tissue with vascular and smooth muscle cells. Case Report. The authors report the case of a 59-year-old African American male who underwent open inguinal hernia repair and was found to have incidentally an angiomyomatous hamartoma, which was excised but complicated with a postoperative lymphocele. The patient was successfully treated with the aid of negative pressure wound therapy. Conclusions. Negative pressure wound therapy has rarely been used to treat postoperative lymphocele. To the authors’ knowledge, this case is the first to document use of negative pressure wound therapy for lymphocele following angiomyomatous hamartoma excision.